Delivery Order SPE2DB20D1100-SPE2DB25FD3M3
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $29,003.35 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of CellCept 500 mg tablets (500-count units). This is a firm fixed price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 2, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $2,987.17. The contract is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025 and was competitively awarded with no set-aside designation. The award is funded by the Medical Supply Chain, a defense-oriented federal agency, with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,228.25 to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The $16,382.12 firm fixed price contract has a period of performance through June 13, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 29, 2025, for 500 mg mycophenolate tablets (500-count) valued at $1,809.24. This firm fixed-price, non-set-aside delivery order is part of the company's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The contract is funded by...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,758.80 firm fixed-price contract is for the delivery of 4,568,078,056 units of the medication CellCept 250 mg capsules by April 30, 2025. The award is not designated as a set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,173.43 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed-price contract, with an ultimate completion date of July 31, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,750.59 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of July 31, 2025. The award was made on a competitive, non-set-aside basis and represents a small-value pharmaceutical supply transaction consistent with the company's extensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,598.56 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. This firm fixed price contract, designated as a child order under a larger vehicle, represents a competitive award with no set-aside provisions. The delivery order is scheduled for ultimate completion on August 1, 2025, with performance taking place at the contractor's Conshohocken facility. This...